US Supreme Court penalizes pharmaceutical companies against FDA-approved drug labeling
While the United States Supreme Court approved a petition to clear up misunderstanding over the drug-labeling mandates by the FDA, both the pharmaceutical companies and the public would gain benefit should they re-examine the rules set by the drug-regulating agency.